Search CommunityWalk:


Chantilly BioPharma LLC.

3701 Concorde Parkway, Unit 500
Chantilly, VA 20151, USA

Category: BioManufacturing; Research Services & Supplies; Suppliers (CRO)

Used in the following map:

Maryland Biotech Industry Map

Chantilly BioPharma LLC. is a development, manufacturing, commercialization, licensing and marketing specialty product pharmaceutical company. The mission of the company is to establish a portfolio of value-added oral drug delivery systems, innovative multiple advanced technologies with a broad range of product applications in different therapeutic categories, develop product profiles which exhibit improved compliance and easier administration, controlled blood levels of drugs, improved efficacy, reduced side effects and expanded indications, increase shareholder value, solid revenue base from development, manufacturing, licensing, marketing and product sales with good profit margins and sustainable growth, develop human capital for continuous innovation, manufacturing quality products that meet FDA cGMP and other U.S and International regulatory requirements.

Chantilly BioPharma's facility includes state-of-the-art cGMP development; Quality Control & Analytical; and manufacturing capabilities. The company's business development services include out-licensing of pipeline products, in-licensing of new product opportunities, partnered product development and pharmaceutical contract services. The company's capabilities include: Specialty drug development for prescription products, Clinical and contract manufacturing, Analytical, stability and packaging services, Proprietary technology application for Modified Release, Orally Disintegrating Tablets and Taste masking and Bioenhancement. CBL has developed products in numerous therapeutic categories include: Cardiovascular, Gastro-Intestinal Tract, Central Nervous Systems, Pain Management and Metabolic. Its analytical and stability services include: 1) Raw Materials for physical characterization; differential scanning calorimetry; release testing and compatibility testing, 2) Drug Substance Analysis for impurity characterization; degradation characterization; particle size characterization and organic volatile impurities, 3) Drug Product Analysis for dissolution; impurity analysis; laser diffraction PSA and residual solvent analysis, 4) Microscopic/Spectral Evaluation for scanning electron microscopy; elemental analysis; particle size image analysis; micro-FT-IR; FT- Raman module and hot stage analysis for melt processing and 5) Stability Chambers - 3 walk-in (ICH conditions); 1 reach-in and photostability. Its formulation and clinical manufacturing services include: Granulation, Compression, Ceform Microsphere Process, etc.

Chantilly BioPharma is involved in the commercialization of products incorporating its Ceform(TM), Smart Coat(TM), KORTABS(TM), Beads, Matrix, Layered, Flash Dose(TM) and Shearform(TM), technologies for use in microsphere processing, modified release drug delivery, orally disintegrating tablets and drug solubility/bioenhancement. Its products therapeutics categories include: Cardiovascular (Calcium Channel, blockers etc.), Gastro-Intestinal products (Ulcerative Colitis, etc.), Pain Management (Opiates, NSAIDS, etc.), CNS (Antidepressants, Anti-anxiety, etc.) and Metabolic (Anti-diabetics). The Company is registered with FDA, DEA and other appropriate regulatory authorities.